retatrutide weight loss injection CutKilo | Phase III retatrutide study demonstrates

While semaglutide and tirzepatide have reshaped how clinicians and patients think about obesity and cardiometabolic disease, retatrutide arrives as the next step in what is effectively a pharmacological arms race toward the most potent weight-loss therapy ever developed

Contact your GP or diabetes specialist promptly if you experience severe persistent vomiting or diarrhoea, severe abdominal pain (particularly radiating to the back), signs of hypoglycaemia, symptoms of gallbladder problems, vision changes, or unexplained persistent nausea beyond the first few weeks

These drugs are toolsnot magic bulletsand should always be used under proper medical supervision

We aim to eliminate conflicting information and ensure every clinic is described in a trustworthy, transparent manner

If the injection is deeper, it is then called an intramuscular injection